GE Healthcare Inc

GE HealthCare’s recent insider RSU sales reveal routine tax‑planning, not distress—yet AI‑pipeline risks and regulatory delays could shape future growth.

GE HealthCare secures CE Mark for Photonova Spectra, boosting its photon‑counting CT reach in Europe with ultra‑high‑definition imaging, faster workflows, and strong value‑based ROI prospects.

GE HealthCare’s Q2 earnings show revenue growth, EPS beat, and a robust order book, while a new interim CFO underscores continuity amid shifting healthcare data and reimbursement regulations.

GE HealthCare Q2 2026: 6% revenue rise, 16% EPS boost, and interim CFO George Newcomb’s leadership keeps investors confident amid industry shifts.

GE HealthCare’s latest officer‑owned share purchase reveals confidence and highlights the firm’s focus on cost‑effective, AI‑driven tech to meet shifting value‑based care demands.

GE Healthcare Technologies insider purchase signals confidence; strong AI‑driven imaging, R&D growth, supply‑chain resilience, and FDA pre‑cert boost future prospects.

Insider buys at GE HealthCare reveal executive confidence, yet analysts trim targets and a fiduciary‑duty probe looms—read the full impact on stock and strategy.

GE Healthcare Q1 earnings miss hits stock; revenue up 3.8% while margins shrink. Analysts weigh inflation, supply‑chain, and AI‑driven growth prospects.

GE Healthcare expands its $35 M BARDA partnership to develop AI‑enabled ultrasound, speeding trauma diagnostics, cutting costs and easing operator demands.

GE Healthcare’s latest earnings beat, analyst lift, and institutional moves reveal a cautious outlook amid regulatory and AI‑driven competition, highlighting risks and growth prospects.